|
- Vasant Narasimhan | Novartis
Vasant (Vas) Narasimhan, M D , has been Chief Executive Officer (CEO) of Novartis since February 1, 2018
- Vasant Narasimhan - Wikipedia
Vasant " Vas " Narasimhan (born August 26, 1976) is an American physician and the chief executive officer of Novartis [1][2][3][4] He succeeded Joseph Jimenez who left Novartis in 2018 [5]
- Vas Narasimhan - Reimagining medicine as CEO of Novartis | LinkedIn
As CEO, I’ve worked to focus our company and unleash the power of our people to spur breakthrough innovation
- Novartis CEO and Key Executive Team - Craft. co
Novartis's Chief Executive Officer is Vasant Narasimhan Other executives include Kees Roks, Chief Audit Officer; Harry Kirsch, Chief Financial Officer and 21 others See the full leadership team at Craft
- Vasant Narasimhan | CEO of Novartis | Leader in Global Healthcare
Vasant Narasimhan is at the forefront of the pharmaceutical industry as CEO of Novartis His innovation makes an impact on global health
- HIGHLIGHTS: Vasant Narasimhan - CEO of Novartis | Norges Bank . . .
Nicolai Tangen speaks with Vasant 'Vas' Narasimhan, CEO of Novartis, about pioneering pharmaceutical innovation They explore breakthrough cell and gene therapies, AI partnerships with leading tech companies, and how Novartis transformed from a sprawling conglomerate into a streamlined drug discovery company
- Vasant Narasimhan Bio – Novartis CEO - The Official Board
Vasant Narasimhan joined Novartis in 2007 Vasant served as Global Head, Development, Vaccines and Diagnostics and Global Head of Drug Development and Chief Medical Officer for Novartis
- Novartis CEO Vas Narasimhan named to 2025 TIME100 Health list
Novartis has announced that CEO Vas Narasimhan, M D , has been named to the 2025 TIME100 Health list—recognizing 100 of the most influential people driving the future of global health
|
|
|